Aileen I Fernandez's postdoctoral research is in translational oncology and focuses on identifying and developing biomarkers to better identify which patients with cancer will respond to different cancer treatments, improving patient care.
Aileen completed her PhD in the Tumor Biology training program at Georgetown University (GU) in 2019. While there, she worked in the laboratory of Dr. Rebecca B. Riggins and focused on triple negative breast cancer, an aggressive breast cancer subtype that disproportionally affects African-American women and lacks targeted therapies. Her work encompassed studying orphan nuclear receptor estrogen-related receptor beta (ERRb) expression and culminated in characterization of ERRb in vitro, in silico, and in tissues. While at GU, Aileen co-founded the Women in Science and Education (WISE) group with her colleagues, serving as the group’s strategist, secretary, and diversity liaison.
Aileen is passionate about leveling accessibility in science and promoting diversity, equity, and inclusion. She also strongly believes in improving science communication to better disseminate information from the scientists’ bench to society. Since joining Yale, she has co-founded the Yale School of Medicine Black Postdoctoral Association, and co-founded the Yale Postdoctoral Association's (YPA) Racial Justice Subcommittee, co-coordinates the YPA Professional Development committee, and has joined the Department of Pathology's DICE committee. She actively works on initiatives with other postdocs to highlights the needs of URM postdocs and how we can address them to increase retention in academia.
Education & Training
- PhDGeorgetown University, Tumor Biology (2019)
- MScUniversity of the District of Columbia, Cancer biology, prevention, and control (2013)
- BSSUNY Purchase, Biology (2010)